HarnessYourBeauty.com
  • Food
  • Mental Health
  • Medical News
  • Sleep and Health
Medical News

FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division

by admin May 7, 2025
May 7, 2025

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.

Prasad, a professor at the University of California San Francisco, became a harsh critic of the government’s response and its vaccine policies during the Covid-19 pandemic. He replaces Dr. Peter Marks, who helped lead the division for 13 years and shaped the Operation Warp Speed effort to rapidly develop Covid-19 vaccines and treatments.

Marks resigned from the agency in March with a letter criticizing US Health and Human Services Secretary Robert F. Kennedy Jr.’s stance on vaccine safety.

“It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies,” Marks wrote.

Prasad has vocally criticized the Warp Speed effort, and Marks’ leadership, on his blog and the social media platform X, where he was often praised by now-FDA Commissioner Dr. Marty Makary for criticizing school shutdowns, mask policies and booster recommendations for the Covid-19 shot.

Prasad’s appointment to lead the Center for Biologics Evaluation and Research comes as the FDA says it will impose new requirements for future vaccines to undergo placebo studies.

Public health officials are also weighing a reversal on Covid-19 vaccine recommendations for children. Prasad has vocally questioned authorizing those shots for children, because they are at lower risk of severe infection than older people and those with weakened immune systems.

Biotech stocks tumbled more than 5% in the hours after the announcement as industry analysts called Prasad an “anti-establishment” choice and noted that he has also questioned the FDA’s used of accelerated approval processes for certain medicines.

Sarepta Therapeutics, manufacturer of one of those accelerated new medicines, saw its stock fall by nearly a quarter. Prasad has been critical of the FDA’s decision to approve Sarepta’s Elevidys, a multimillion-dollar gene therapy to treat Duchenne muscular dystrophy, despite what he saw as limited evidence of its benefits.

Prasad co-wrote a post last year that said, “Despite its high cost and potential toxicity, the clinical benefits of Elevidys remain uncertain.”

Under his leadership, the biologics division could bring more scrutiny and requirements to developers creating new gene therapies. Earlier this year, Prasad said he wanted to see more stringent reviews, writing on X that “The FDA did nothing to speed gene therapy, other than talk about how they will use uncontrolled endpoints. But we want to speed effective gene therapy, not ineffective gene therapy. The FDA had no solution for that.”

Biotech stocks were “nearly as weak” Tuesday as they were the day after President Trump announced that Kennedy would lead HHS, Mizuho Group analyst Jared Holz wrote in a note to investors.

This post appeared first on cnn.com
previous post
Utah’s ban on fluoride in public water is a simple change that raises complicated new health risks, experts say
next post
US surpasses 1,000 measles cases in 2025, second worst year since disease was declared eliminated

You may also like

A West Virginia prosecutor is warning women that...

June 6, 2025

Despite Kennedy’s claims, vaccines have been tested in...

June 5, 2025

Trump administration rolls back guidance specifying that ERs...

June 5, 2025

Texas girl thriving after fish skin helped heal...

June 4, 2025

New research presents promising findings on colorectal cancer...

June 2, 2025

Pfizer CEO: HHS claims of ‘concealed safety concerns’...

June 2, 2025

Covid-19 shots for kids remain on CDC vaccine...

May 31, 2025

How changes to Covid-19 vaccine policy in the...

May 31, 2025

Removing fluoride from public drinking water may lead...

May 31, 2025

HHS cancels $590 million contract with Moderna for...

May 29, 2025
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • Eating more ultraprocessed food ups the risk of premature death, study finds

    June 2, 2025
  • How to cook tofu so even meat-and-potatoes diners will dig it

    June 2, 2025
  • Gwyneth Paltrow has started eating carbs and cheese again

    June 2, 2025
  • Rising food prices in US getting in way of healthy eating, survey of Americans finds

    June 2, 2025
  • What eliminating artificial food dyes could mean for the food system

    June 2, 2025
  • Contacts
  • Email Whitelisting
  • Privacy Policy
  • Terms and Conditions

Copyright © 2025 HarnessYourBeauty.com All Rights Reserved.


Back To Top
HarnessYourBeauty.com
  • Food
  • Mental Health
  • Medical News
  • Sleep and Health